Introduction {#s1}
============

Major depressive disorder (MDD) is a debilitating psychiatric mood disorder with a lifetime prevalence of 16% that contributes to increased rates of disability and suicide ([@CIT0053]; [@CIT0118]). Stressful life events are the most significant priming factor in the etiology of MDD ([@CIT0051]). However, some individuals are able to successfully cope with acute stress or more prolonged chronic forms of adversity ([@CIT0024]). These ''resilient'' individuals display traits such as cognitive flexibility and optimism ([@CIT0023]). Resiliency is not merely a lack of stress susceptibility; it is an active and adaptive psychological and physiological stress response or "psychobiological allostasis" ([@CIT0022]; [@CIT0024]; [@CIT0092]). This resilient phenotype is important in understanding the underlying biological processes associated with stress susceptibility and resiliency ([@CIT0011]; [@CIT0106]). However, the neural substrates and molecular mechanisms that mediate resistance to the deleterious effects of stress remain unclear ([@CIT0057]; [@CIT0025]).

As one of most malleable brain regions targeted by stress stimulation ([@CIT0071]), the hippocampus shoulders the responsibility of balancing function and vulnerability to stress damage by adaptive neuron dendritic remodeling, such as growth and shrinkage of dendritic trees and spines ([@CIT0100]; [@CIT0070]). This hippocampal dendritic or spine remodeling is dysregulated in stress-induced depression and stress resilience ([@CIT0020]; [@CIT0032]). In animal models, chronic stress reduces hippocampal neurogenesis ([@CIT0050]; [@CIT0080]; [@CIT0055]) and the complexity of dendritic arbors while impairing function in assays of hippocampal dependent spatial memory ([@CIT0075]; [@CIT0006]) and long-term potentiation ([@CIT0005]). Using noninvasive magnetic resonance methods, hippocampal microstructural variations have been found in both chronic mild stress (CMS)-exposed anhedonic and resilient rats. In contrast, morphological and metabolic changes of the hippocampus allows discrimination of these 2 subtypes, suggesting that stress induces hippocampal reorganization through different pathways (Delgado y [@CIT0019]).

Generally, the signs of hippocampal reorganization were sought by examining the plasticity of dendrites and synapses ([@CIT0059]). Since memories are believed to be stored and maintained in hippocampal synapses ([@CIT0007]), synaptic plasticity is thought to be the cellular mechanism for learning and memory that guides the behavior of an organism ([@CIT0006]). long-term potentiation of synaptic transmission remains the most widely studied example of synaptic plasticity, especially in the hippocampus ([@CIT0040]; [@CIT0066]; [@CIT0048]). Moreover, dysregulation of hippocampal synaptic plasticity has also been implicated in a variety of psychiatric disorders ([@CIT0006]). In animals, chronic stress severely disturbs synaptic plasticity. For example, changes in the strength or efficacy of synaptic transmission result in hippocampal structural and functional incoordination ([@CIT0100]; [@CIT0056]; [@CIT0040]; [@CIT0084]). In humans, the sustained increase of hippocampal excitatory synaptic transmission following stress may underlie the dendritic remodeling and volumetric shrinkage associated with stress-related pathologies ([@CIT0068]; [@CIT0094]). Alternatively, synaptic plasticity allows the organism to adapt to a constant stress environment even under high-stress conditions, implying that a strong adaptive regulation program over stress pathways may be exerted ([@CIT0015]; Delgado y [@CIT0019]). However, the specific proteins and genes that are required for stress-related synaptic remodeling and adaptation remain unclear ([@CIT0015]). Uncovering these numerous molecular events is critical to both the understanding of the etiology of MDD as well as the anhedonic or resilient nature.

To study the stress-related molecular events intrinsic to the hippocampal synapse, direct approaches to quantitatively address the subtype-specific synaptic proteome are necessary. This can be achieved by biochemically enriching synaptic junctions that are taken from active zone-associated electron-dense structures ([@CIT0081]). Such an approach has the important advantage of revealing localized events that are otherwise hidden in the complexity of molecular changes that occur in other subcellular compartments ([@CIT0081]; [@CIT0002]; [@CIT0017]). Although some synaptic molecules have been intermittently studied by molecular detection techniques at the tissue level from various stressed systems ([@CIT0074]; [@CIT0038]; [@CIT0069]; [@CIT0021]; [@CIT0025]), the distinct picture of these components, particularly at the synaptic active zone, remains elusive.

Here, we carried out nonhypothesis-driven, large-scale proteomic analyses using isobaric tag for relative and absolute quantitation (iTRAQ) coupled with tandem mass spectrometry. We utilized this approach to investigate quantitative changes of proteins from the enriched synaptic junction preparations in a CMS model of depression. This depressive model generates both susceptible and unsusceptible subpopulations, reflecting the 2 hedonic responses to CMS. Our synaptic proteome profiles identified several potential molecular adaptations within the synaptic active zone that may be related to stress vulnerability or insusceptibility and represent differences in important active biological processes specific to stress vulnerability and stress coping strategies.

Materials and Methods {#s2}
=====================

A detailed description of the materials and methods used in this study is provided in the [supplementary Methods](http://ijnp.oxfordjournals.org/lookup/suppl/doi:10.1093/ijnp/pyv100/-/DC1).

Animal Subjects and CMS Protocol {#s3}
--------------------------------

Male Sprague-Dawley rats from the Animal Facility of Chongqing Medical University were used. The CMS protocol was then performed according to previously described methods ([@CIT0115]; [@CIT0034]; [@CIT0043]; [@CIT0119]). Details of the procedure including time and length of stressors are presented in [Figure 1a](#F1){ref-type="fig"}.

![Chronic mild stress (CMS) schedule and sucrose preference test. (*a*) Time and length of stressors used in the CMS procedure. (*b*) Sucrose preference during the CMS protocol. By the third week of CMS procedure, sucrose preference was significantly decreased in the susceptible rats compared with the control and unsusceptible rats (n=19). This relationship continued into the fourth week of CMS as well. \*\*\**P\<.*001.](ijnppy_pyv100_f0001){#F1}

Behavioral Experiments {#s4}
----------------------

The sucrose preference test ([@CIT0043]), open-field test (OFT) ([@CIT0119]), and forced swimming test (FST) ([@CIT0085]) were conducted as previously described.

Sample Preparation, iTRAQ Labeling, and SCX Fractionation {#s5}
---------------------------------------------------------

Hippocampal synaptic junction-enriched fractions were obtained as previously reported ([@CIT0081]; [@CIT0002]; [@CIT0043]). Then, the synaptic junctional proteins were extracted, digested ([@CIT0116]), and labeled by iTRAQ-4plex reagents (Applied Biosystems) according to the manufacturer's instruction. Labeled peptides were combined and fractionated by strong cation exchange (SCX) chromatography.

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) and Data Analysis {#s6}
---------------------------------------------------------------------------

As described in our previous study ([@CIT0121]), the SCX fractions were analyzed using a TripleTOF 5600 mass spectrometer (AB SCIEX) equipped with a splitless nanoLC-Ultra 2D plus system and a cHiPLC Nanoflex microchip system. Subsequent protein identification and iTRAQ quantitation were performed with ProteinPilot 4.5 software (AB SCIEX) using the Paragon algorithm (4.5.0.0.1654) as the search engine. Identified proteins were grouped by the ProGroup algorithm to minimize redundancy. For quantitative analysis, observed proteins with iTRAQ ratios of \>1.2 and \<0.83 were considered to be differentially expressed, as used in previous studies ([@CIT0063]; [@CIT0122]; [@CIT0114]). All raw and metadata of the proteome have been deposited to the ProteomeXchange with identifier PXD002540.

Bioinformatics Analysis {#s7}
-----------------------

The gene ontology (GO) annotations (including subcellular location and function) of the identified differential proteins were obtained from the UniProt Knowledgebase and the DAVID Database ([@CIT0044]). More detailed descriptions of these differential membrane proteins were derived from SynaptomeDB ([@CIT0083]). Furthermore, the identified proteins involved in membrane trafficking were mapped to the protein interaction network, and STRING was used to qualify the physical and functional interactions of these proteins ([@CIT0118]).

Antibodies and Western-Blot Analyses {#s8}
------------------------------------

For Western blot, the procedures of electrophoresis, transfer, and immunodetection were performed according to our previous study ([@CIT0118]; [@CIT0043]). The primary antibodies used were as follows: antibody for the Ras-related protein Rab-3A (Rab3a, ab3335, 1:2000); syntaxin-binding protein 1 (Stxbp1, Munc18-1, ab124920, 1:4000); synapsin-1 (Syn1, ab18814, 1:1000); syntaxin-1A (Stx1a, ab41453, 1:3000); synaptosomal-associated protein 25 (SNAP25, ab5666, 1:4000); vesicle-associated membrane protein 2 (VAMP2, ab3347, 1:2000); synaptophysin (ab52636, 1:1000) (all purchased from Abcam); synaptotagmin 1 (Syt1, Millipore MAB5200, 1:1000); syntaxin-1B (Stx1b, Synaptic Systems 110402, 1:1000); and PSD95 (CST \#3450, 1:1000). Horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgG (purchased from Bio-Rad, dilution 1:15000) were used as secondary antibodies. After immunodetection, the intensity of the immunostained bands were normalized for the total protein intensities measured by Coomassie blue from the same blot ([@CIT0109]; [@CIT0016]). The images were subjected to densitometric analysis performed using Quantity One software (Bio-Rad).

Statistical Analysis {#s9}
--------------------

The sucrose preference test, OFT, and FST data were analyzed using SPSS 16.0, as described in our previous study ([@CIT0043]; [@CIT0119]). Meanwhile, the data from Western blots of protein expression were compared using Student's *t* tests. The level of statistical significance for all analysis was set at *P*\<.05. Statistics were presented as means ±SE.

RESULTS {#s10}
=======

CMS-Induced Behavioral Assessment {#s11}
---------------------------------

Here, sucrose preference was applied to assess the stress-induced anhedonic-like (susceptible) and stress-resilient (unsusceptible) behavior of rats. A subset of the controls, susceptible, and unsusceptible rats (n=19 in each group), were used in the following analysis. Repeated measurement ANOVA showed that, for sucrose preference, the impact of the treatment factor (F(2, 54)=6.745, *P*\<.001) and interaction between time and treatment (F(8, 216)=8.176, *P\<.*001) were significant. MANOVA indicated that 3-week exposure to CMS resulted in significantly decreased sucrose preference of the susceptible group when compared with the control and unsusceptible groups (F(2, 54)=14.725, *P\<.*001). This difference remained significant following 4 weeks of CMS (F(2, 54)=53.253, *P\<.*001) as shown in [Figure 1b](#F1){ref-type="fig"}.

In OFT, the CMS protocol did not alter locomotor activity ([Figure 2a](#F2){ref-type="fig"}). The rearing number was significantly decreased in susceptible and unsusceptible rats relative to controls (*P\<.*01 and *P\<.*05, respectively), indicating decreased exploratory behavior in these groups ([Figure 2b](#F2){ref-type="fig"}). Time spent in the central sector was used to reflect the degree of anxiety (ie, animals displaying higher activity levels in the center of the arena were defined as less anxious). Compared with the control and unsusceptible animals, the susceptible animals spent a shorter amount of time in the center square (*P\<.*01 and *P\<.*05, respectively), indicating higher anxiety in this population ([Figure 2c](#F2){ref-type="fig"}). In FST, immobility time was significantly elevated in the susceptible rats as compared with the control and the unsusceptible groups (*P\<.*01 and *P\<.*05, respectively). There was no significant difference between the control and unsusceptible groups, indicating that the increase in immobility time in chronically stressed rats is related to anhedonic status ([Figure 2d](#F2){ref-type="fig"}).

![Results of behavioral testing. Comparisons of (*a*) total distance moved, (*b*) number of rearings, (*c*) time spent in the central sector of the open-field test (OFT), and (*d*) immobility times in the forced swimming test (FST) between the control, susceptible, and unsusceptible rats are shown. \**P\<.*05, \*\**P\<.*01.](ijnppy_pyv100_f0002){#F2}

Quantitative Proteomic Analysis of Hippocampal Synaptic Junctions {#s12}
-----------------------------------------------------------------

To identify differentially expressed proteins involved in mediating synaptic plasticity and neurotransmission in the hippocampus, we performed quantitative proteomics using an iTRAQ-based shotgun quantitation approach on fractions containing synaptic junctions derived from the hippocampi of groups of rats subjected to CMS conditions ([@CIT0121]). An overview of the sample preparation and iTRAQ workflow conducted is shown in [Figure 3](#F3){ref-type="fig"}. Rat hippocampi tissue was subject to biochemical fractionation to obtain total homogenate (Hom), synaptosome (Syn), synaptic vesicular (Ves), and synaptic junction fractions. The resulting 4 fractions were analyzed to confirm expected enrichment by Western blot for appropriate marker proteins. As expected, the Ves fraction was enriched with the synaptic vesicle protein synaptophysin and free of PSD95, while the synaptic active zone protein Stx1a was mainly located in the synaptic junction fraction, demonstrating that our fractionation was effective ([Figure 4](#F4){ref-type="fig"}). For quantitative proteomic analysis, iTRAQ labeling was performed on the synaptic junction preparation. After SCX fractionation and subsequent LC-MS/MS analysis, all protein and peptide identifications were obtained using the ProteinPilot search engine. The detailed protein identification and quantitation from 2 independent biological replicates are listed in [supplementary Table 1](http://ijnp.oxfordjournals.org/lookup/suppl/doi:10.1093/ijnp/pyv100/-/DC1). For all peptide matches with 95% confidence, the number of iTRAQ-labeled N-termini and lysines was compared with the total number of peptide N-termini and lysines ([@CIT0082]; [@CIT0060]). The iTRAQ labeling efficiency was estimated to be 99.1% and 98.7% in datasets 1 and 2, respectively. A summary of the protein identification results is presented in [Table 1](#T1){ref-type="table"}. A total of 4562 distinct proteins was identified with at least 1 unique peptide and an estimated false discovery rate of 1% (2931 with more than 2 unique peptides); of these, 2620 (57%) were identified in both sets and 4318 proteins were quantified with 2344 (54%) overlapping in the replicate data sets. For further analysis, the proteins with \<3 unique peptides (95% confidence) or error factor \>2.0 were eliminated in the overlapping quantified proteins ([@CIT0110]). The exclusion criteria resulted in 1671 quantified proteins (see [supplementary Table 2](http://ijnp.oxfordjournals.org/lookup/suppl/doi:10.1093/ijnp/pyv100/-/DC1)). The change in relative concentration of any given protein for the susceptible and unsusceptible groups relative to controls was obtained from the iTRAQ 4-plex reporter ion ratios by calculating a weighted average of all the confidently identified peptides assigned to any given protein. iTRAQ reporter ratios of 1.2 and 0.83 were set as the cut-off of protein changes ([@CIT0063]; [@CIT0122]; [@CIT0114]). Together with the 2 datasets, a total of 121 significantly altered proteins hits (either down- or upregulated) were statistically screened out for the respective sample comparisons. MS/MS spectra along with reporter ions of peptides belonging to representative proteins were shown in [Figure 5](#F5){ref-type="fig"}.

![Outline of the sample preparation and isobaric tag for relative and absolute quantitation (iTRAQ) labeling procedures. Rat hippocampi were dissected from the 3 groups (control, susceptible, and unsusceptible). The tissue was subject to biochemical fractionation to obtain total homogenate (Hom), synaptosome (Syn), and synaptic vesicular (Ves) fractions. iTRAQ labeling was performed on the synaptic junction preparation. Two sets of biological replicate samples were analyzed using 4-plex iTRAQ reagents. Peptides from controls were labeled with iTRAQ reagent having 115 and 116 reporters, peptides from the susceptible group were labeled with iTRAQ reagent having 116 and 114 reporters, and peptides from the unsusceptible group were labeled with iTRAQ reagent having 114 and 115 reporters. After labeling, peptides from all 6 samples were separately combined and fractionated by strong cation exchange (SCX) chromatography. Each fraction was then analyzed by LC-MS/MS on a Triple TOF 5600 mass spectrometer.](ijnppy_pyv100_f0003){#F3}

![Western-blot analysis of the 4 fractions (Hom, Syn, Ves, and synaptic junction) obtained by biochemical fractionation. The fractions were analyzed using antibodies against synaptophysin (synaptic vesicle marker), Stx1a (synaptic active zone marker), and PSD95 (postsynaptic density marker).](ijnppy_pyv100_f0004){#F4}

###### 

Comparison of the Two Sets of Biological Replicate Samples

  -------------------------------------------------------------------------------------------------------------
  Summary Data                                                    Set 1                  Set 2
  --------------------------------------------------------------- ---------------------- ----------------------
  Total number of protein IDs^*a*^                                3691                   3491

  Number of unique proteins from each set^*b*^                    1071                   871

  Combined distinct protein IDs (total/overlap) from the 2 sets   4562/2620              

  Reproducibility of protein IDs in the 2 sets                    71.0%                  75.1%

  Total proteins with iTRAQ ratio                                 3625 (98.2%)           3037 (87.0%)

  Unique proteins with iTRAQ ratio from each set                  1281                   693

  Combined distinct protein IDs with iTRAQ ratio\                 4318/2344              
  (total/overlap) from the 2 sets                                                        

  Reproducibility of protein IDs with iTRAQ ratio in 2 sets       64.7%                  77.2%

  Total peptides/unique peptides                                  125708/26528 (21.1%)   106165/24160 (22.8%)

  Unique peptides identified in only 1 set                        10519                  8151

  Combined unique peptides (total/overlap) from the 2 sets        34679/16009            
  -------------------------------------------------------------------------------------------------------------

Abbreviation: iTRAQ, isobaric tag for relative and absolute quantitation.

^*a*^The total number of protein IDs indicates the total protein IDs identified based on at least one unique peptide in the 2 sets of biological replicate samples.

^*b*^The number of unique proteins from each set denotes the number of protein IDs exclusively identified from each of the 2 sets.

![MS/MS spectra of peptides with their reporter ions for representative differentially expressed proteins in datasets 1 and 2. (*a*) MS/MS spectrum of a representative peptide (ASTAAPVASPAAPSPGSSGGGGFFSSLSNAVK) from Syn1 and corresponding spectrum showing relative intensity of reporter ions. (*b*) MS/MS spectrum of a representative peptide (DEPHTDWAK) from Syn2 and corresponding spectrum of reporter ions.](ijnppy_pyv100_f0005){#F5}

Identity Categorization of Differentially Expressed Proteins {#s13}
------------------------------------------------------------

The accession numbers of the 121 differential proteins identified from the susceptible and unsusceptible groups were uploaded into the UniProt and DAVID database for categorization of subcellular localization based on their GO annotations. In terms of cellular compartment, the majority of the differential proteins were membrane-associated components, of which 53 (44%) were localized to the plasma membrane and 36 (30%) were classified as organelle membrane proteins ([Figure 6a](#F6){ref-type="fig"}).

![Localization analysis of differentially expressed proteins. (*a*) Pie chart showing the distribution of the differentially expressed proteins across the cellular compartments based on gene ontology (GO) annotations from the UniProt/DAVID database. (*b*) Venn diagram showing the detailed synaptic localization of the differentially expressed membrane-associated proteins based on the SynaptomeDB search.](ijnppy_pyv100_f0006){#F6}

To help focus on synaptic membrane proteins, the detailed subtype localization of 89 differential membrane proteins was further investigated through an integrated database called SynaptomeDB ([Table 2](#T2){ref-type="table"}) ([@CIT0083]). The SynaptomeDB compiled the synaptic protein list from a review of all peer-reviewed proteomic studies and from publicly available databases that included proteins in the post- and presynapse, the presynaptic active zone, and the synaptic vesicle, and it provided a detailed and experimentally verified annotation of all known synaptic proteins. Of these detected differential membrane proteins, 81 (91%) were identified by the SynaptomeDB search as having a predicted synapse-specific localization and are the focus of this study (see [supplementary Table 3](http://ijnp.oxfordjournals.org/lookup/suppl/doi:10.1093/ijnp/pyv100/-/DC1)). [Figure 6b](#F6){ref-type="fig"} shows that 41, 31, and 80 proteins were compartmentalized to the presynapse, presynaptic active zone, and postsynaptic density, respectively, and only 6 proteins belong to the synaptic vesicle. A 4-way Venn diagram approach was used to display the overlap between these categories, and multiple overlapping sets were found. Not surprisingly, there were 23 overlapping proteins between the presynapse and presynaptic active zone. On the other hand, some presynaptic proteins, and particularly the active zone associated proteins, were simultaneously found in the postsynaptic density, suggesting that they remained associated with postsynaptic density. This phenomenon is probably due to the "stickiness" of the biochemically isolated fractions and multiple localization of the synaptic proteins.

###### 

Differential Membrane Proteins Identified from the Hippocampal Synaptic Junctions of Susceptible and Unsusceptible Rats

  Uniprot Accession   Protein Name                                                                                               Gene Name   Unique Peptide   Average Fold Change   Function          
  ------------------- ---------------------------------------------------------------------------------------------------------- ----------- ---------------- --------------------- ---------- ------ ------------------------
  P61765              Syntaxin-binding protein 1                                                                                 Stxbp1      69               64                    ―          1.43   Membrane trafficking
  P09951              Synapsin-1                                                                                                 Syn1        97               89                    ―          1.86   Membrane trafficking
  G3V733              Synapsin II, isoform CRA_a                                                                                 Syn2        41               45                    ―          1.96   Membrane trafficking
  F1M7V4              Protein piccolo                                                                                            Pclo        54               61                    ―          1.39   Membrane trafficking
  B0BMW0              RAB14, member RAS oncogene family                                                                          Rab14       7                6                     ―          1.34   Membrane trafficking
  Q641Z6              EH domain-containing protein 1                                                                             Ehd1        21               26                    1.39       1.55   Membrane trafficking
  Q812E9              Neuronal membrane glycoprotein M6-a                                                                        Gpm6a       5                7                     2.03       1.58   Membrane trafficking
  Q6AXT5              Ras-related protein Rab-21                                                                                 Rab21       6                7                     2.53       ―      Membrane trafficking
  O54923              Exocyst complex component 6                                                                                Exoc6       4                7                     ―          0.79   Membrane trafficking
  P54921              Alpha-soluble NSF attachment protein                                                                       Napa        15               21                    0.69       0.75   Membrane trafficking
  P63012              Ras-related protein Rab-3A                                                                                 Rab3a       7                8                     0.56       0.43   Membrane trafficking
  G3V6D3              ATP synthase subunit beta                                                                                  Atp5b       46               56                    0.59       1.76   Transporter
  P62815              V-type proton ATPase subunit B, brain isoform                                                              Atp6v1b2    40               35                    ―          1.57   Transporter
  G3V7L8              ATPase, H+ transporting, V1 subunit E isoform 1, isoform CRA_a                                             Atp6v1e1    20               17                    ―          1.55   Transporter
  D4A133              Protein Atp6v1a                                                                                            Atp6v1a     41               39                    ―          1.22   Transporter
  P31596              Excitatory amino acid transporter 2                                                                        Slc1a2      12               15                    0.72       ―      Transporter
  Q6P6T0              Sideroflexin 3                                                                                             Sfxn3       4                7                     0.60       ―      Transporter
  P07340              Sodium/potassium-transporting ATPase subunit beta-1                                                        Atp1b1      10               11                    0.56       ―      Transporter
  P15999              ATP synthase subunit alpha, mitochondrial                                                                  Atp5a1      39               52                    0.70       ―      Transporter
  P46462              Transitional endoplasmic reticulum ATPase                                                                  Vcp         30               30                    0.52       ―      Transporter
  G3V7Q0              Protein Dennd5a                                                                                            Dennd5a     3                4                     ―          0.66   Transporter
  G3V8Q1              Coatomer protein complex, subunit epsilon (Predicted), isoform CRA_c                                       Cope        5                7                     ―          0.65   Transporter
  B0BNJ1              LOC683667 protein                                                                                          Sri         5                4                     0.58       0.68   Transporter
  Q6P9Y4              ADP/ATP translocase 1                                                                                      Slc25a4     10               11                    0.74       0.52   Transporter
  F1LXF1              Protein Bcr (Fragment)                                                                                     Bcr         13               8                     1.42       2.17   Signaling
  Q8K3M6              ERC protein 2                                                                                              Erc2        17               27                    ―          1.55   Signaling
  Q9Z1T4              Connector enhancer of kinase suppressor of ras 2                                                           Cnksr2      10               13                    ―          1.28   Signaling
  Q66HA6              ADP-ribosylation factor-like protein 8B                                                                    Arl8b       4                3                     ―          1.60   Signaling
  Q6RUV5              Ras-related C3 botulinum toxin substrate 1                                                                 Rac1        11               16                    1.53       ―      Signaling
  P82471              Guanine nucleotide-binding protein G(q) subunit alpha                                                      Gnaq        4                3                     1.21       ―      Signaling
  P11730              Calcium/calmodulin-dependent protein kinase type II subunit gamma                                          Camk2g      10               12                    1.46       ―      Signaling
  Q6DUV1              Protein kinase C epsilon                                                                                   Prkce       19               18                    0.64       ―      Signaling
  P61983              14-3-3 protein gamma                                                                                       Ywhag       10               9                     0.62       ―      Signaling
  P13233              2',3'-cyclic-nucleotide 3'-phosphodiesterase                                                               Cnp         31               29                    0.77       ―      Signaling
  B5DFC4              Protein kinase C                                                                                           Prkca       10               6                     ―          0.60   Signaling
  Q9QXK0              Signal transducer and activator of transcription 1                                                         Stat1       4                4                     ―          0.70   Signaling
  P47942              Dihydropyrimidinase-related protein 2                                                                      Dpysl2      24               27                    0.59       0.71   Signaling
  P62260              14-3-3 protein epsilon                                                                                     Ywhae       22               21                    0.49       0.72   Signaling
  P63102              14-3-3 protein zeta/delta                                                                                  Ywhaz       12               14                    0.51       0.65   Signaling
  Q8VIN2              Annexin                                                                                                    Anxa7       6                7                     1.76       1.99   Regulatory/Chaperone
  Q5U355              Itfg1 protein                                                                                              Itfg1       5                3                     2.11       1.39   Regulatory/Chaperone
  O35274              Neurabin-2                                                                                                 Ppp1r9b     22               23                    1.46       ―      Regulatory/Chaperone
  B0K020              CDGSH iron-sulfur domain- containing protein 1                                                             Cisd1       5                7                     1.47       ―      Regulatory/Chaperone
  Q05175              Brain acid soluble protein 1                                                                               Basp1       16               13                    0.69       ―      Regulatory/Chaperone
  F1LP80              Neurosecretory protein VGF                                                                                 Vgf         5                4                     0.50       ―      Regulatory/Chaperone
  P14669              Annexin A3                                                                                                 Anxa3       18               15                    0.53       ―      Regulatory/Chaperone
  O35095              Neurochondrin                                                                                              Ncdn        15               14                    0.72       ―      Regulatory/Chaperone
  O35796              Complement component 1 Q subcomponent-binding protein, mitochondrial                                       C1qbp       8                8                     0.74       ―      Regulatory/Chaperone
  Q66HD0              Endoplasmin                                                                                                Hsp90b1     21               16                    0.55       ―      Regulatory/Chaperone
  Q6P502              T-complex protein 1 subunit gamma                                                                          Cct3        23               21                    0.73       ―      Regulatory/Chaperone
  Q9ERS3              Voltage-dependent calcium channel subunit alpha-2/delta-1                                                  Cacna2d1    31               29                    1.50       1.98   Receptor/Channel
  O88871              Gamma-aminobutyric acid type B receptor subunit 2                                                          Gabbr2      14               8                     1.68       ―      Receptor/Channel
  Q9Z2L0              Voltage-dependent anion- selective channel protein 1                                                       Vdac1       49               54                    1.45       ―      Receptor/Channel
  D4A3H5              Protein Clcn6                                                                                              Clcn6       10               10                    1.38       ―      Receptor/Channel
  Q63622              Disks large homolog 2                                                                                      Dlg2        36               30                    1.36       1.60   Scaffolding/Clustering
  Q62765              Neuroligin-1                                                                                               Nlgn1       5                3                     ―          1.51   Scaffolding/Clustering
  Q8R490              Cadherin 13                                                                                                Cdh13       13               11                    ―          1.51   Cell adhesion
  Q9Z2S9              Flotillin-2                                                                                                Flot2       21               20                    ―          1.53   Cell adhesion
  D4A8Y0              Protein Cldn12                                                                                             Cldn12      3                3                     ―          1.25   Cell adhesion
  D4A435              Protein Icam5                                                                                              Icam5       27               27                    0.66       0.54   Cell adhesion
  P30427              Plectin                                                                                                    Plec        149              145                   2.04       2.01   Cytoskeletal
  F1LSL8              Protein Sptbn4                                                                                             Sptbn4      56               43                    1.56       1.75   Cytoskeletal
  A2VCW8              Septin 7                                                                                                   Sept7       33               29                    ―          1.46   Cytoskeletal
  Q07266              Drebrin                                                                                                    Dbn1        23               18                    1.55       ―      Cytoskeletal
  F1LSW1              Unconventional myosin-Ib                                                                                   Myo1b       5                5                     1.26       ―      Cytoskeletal
  Q91ZN1              Coronin-1A                                                                                                 Coro1a      10               7                     1.36       ―      Cytoskeletal
  Q561S0              NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 10, mitochondrial                             Ndufa10     17               12                    2.37       5.78   Mitochondrial
  P04636              Malate dehydrogenase, mitochondrial                                                                        Mdh2        17               17                    1.38       2.15   Mitochondrial
  Q68FY0              Cytochrome b-c1 complex subunit 1, mitochondrial                                                           Uqcrc1      24               20                    1.37       1.99   Mitochondrial
  P20788              Cytochrome b-c1 complex subunit Rieske, mitochondrial                                                      Uqcrfs1     7                10                    ―          2.40   Mitochondrial
  P11240              Cytochrome c oxidase subunit 5A, mitochondrial                                                             Cox5a       15               17                    ―          1.67   Mitochondrial
  B2RYS2              Cytochrome b-c1 complex subunit 7                                                                          Uqcrb       7                10                    ―          1.55   Mitochondrial
  P11951              Cytochrome c oxidase subunit 6C-2                                                                          Cox6c2      5                6                     ―          1.61   Mitochondrial
  Q6P6R2              Dihydrolipoyl dehydrogenase, mitochondrial                                                                 Dld         33               30                    ―          1.41   Mitochondrial
  Q5XI78              2-oxoglutarate dehydrogenase, mitochondrial                                                                Ogdh        48               49                    0.65       ―      Mitochondrial
  P10860              Glutamate dehydrogenase 1, mitochondrial                                                                   Glud1       36               45                    0.57       ―      Mitochondrial
  P08461              Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial   Dlat        23               19                    0.55       0.64   Mitochondrial
  P49432              Pyruvate dehydrogenase E1 component subunit beta, mitochondrial                                            Pdhb        19               19                    0.53       0.54   Mitochondrial
  Q5HZW3              Aspartate beta-hydroxylase domain-containing protein 2                                                     Asphd2      4                3                     1.60       2.25   Metabolic
  G3V9W6              Aldehyde dehydrogenase                                                                                     Aldh3a2     4                6                     1.65       1.36   Metabolic
  Q5XI31              GPI transamidase component PIG-S                                                                           Pigs        4                3                     1.23       ―      Metabolic
  Q66HL0              5′ nucleotidase, ecto                                                                                      Nt5e        8                8                     1.47       ―      Metabolic
  D3ZPU3              Estradiol 17-beta-dehydrogenase 12                                                                         Hsd17b12    8                5                     1.57       ―      Metabolic
  B5DEH2              Erlin-2                                                                                                    Erlin2      7                5                     1.33       ―      Metabolic
  P07335              Creatine kinase B-type                                                                                     Ckb         15               17                    0.35       ―      Metabolic
  P04797              Glyceraldehyde-3-phosphate dehydrogenase                                                                   Gapdh       36               41                    0.51       ―      Metabolic
  P12785              Fatty acid synthase                                                                                        Fasn        50               44                    0.71       0.67   Metabolic
  Q4FZZ4              Pyruvate dehydrogenase (Lipoamide) alpha 1                                                                 Pdha1       19               17                    0.58       0.64   Metabolic
  I7FKL4              Myelin basic protein transcript variant 1                                                                  Mbp         22               21                    ―          1.46   Other

―, not significantly changed.

Functional Classification of Differential Membrane Proteins {#s14}
-----------------------------------------------------------

Here, we designed a quantitative proteomic experiment to explore global patterns of synaptic protein expression in the hippocampus of control, susceptible, and unsusceptible rats. Our goal was to describe 2 main categories of proteins: (1) proteins regulated similarly in susceptible and unsusceptible groups (as a result of exposure to CMS) and (2) proteins regulated differentially in susceptible and unsusceptible rats (which may mediate differences in behavior). Our results, summarized as Venn diagrams in [Figure 7a](#F7){ref-type="fig"}, revealed that the resilience phenotype was much more closely associated with the upregulation of protein groups as a potentially adaptive response. Despite similar abundance changes between the 2 groups, there were a significant number of proteins that displayed changes in abundance levels that were specific to either susceptible or unsusceptible rats, suggesting differences in the molecular mechanism(s) underlying these 2 phenotypes. Furthermore, only one protein, Atp5b, showed an opposite expression trend after CMS application. That is, compared with the control group, the level of Atp5b was significantly upregulated in the unsusceptible group but was downregulated in the susceptible group.

![Differentially expressed membrane proteins from hippocampal synaptic junctions. (*a*) Venn diagrams showing the number of uniquely regulated proteins in the susceptible and unsusceptible groups as compared to controls, with the overlap depicting proteins that were identically regulated under both conditions. Upregulated (red) and downregulated (blue) proteins are shown separately. (*b*) Pie chart showing classification of these differentially expressed membrane proteins identified from susceptible and unsusceptible groups. The number of membrane proteins in each category is indicated. (*c*) Upregulated and downregulated proteins are indicated by red and blue color codes, respectively, with the color intensity signifying the expression level as noted in the key bar (top right). Histograms denote the expression trend of the representative proteins.](ijnppy_pyv100_f0007){#F7}

For functional characterization of the differential membrane proteins, their molecular functions were categorized on the basis of their GO functional annotations and literature surveys ([@CIT0004]), though this classification is not strict due to the multiple functions of each protein ([@CIT0123]). The identified proteins were classified into 11 functional categories ([Figure 7b](#F7){ref-type="fig"}). From the figure, proteins were involved in extensive synaptic functions, including membrane trafficking, transporter, signaling, regulatory/chaperone, receptor/channel, scaffolding/clustering, cell adhesion, cytoskeletal, mitochondria, metabolic, and other functions. We observed that up to 28% of these differential membrane proteins participated in membrane trafficking and vesicle-mediated transport based on the biological process GO analysis. These proteins have been found to be involved in exocytosis and endocytosis, synaptic vesicle transport and docking, and regulation of the neurotransmitter cycle ([@CIT0089]; [@CIT0096]).

To further investigate the relationship between functional clusters and expressional alterations, the dysregulated phenotypes of these differential membrane proteins in each category were systematically analyzed by heatmapping. [Figure 7c](#F7){ref-type="fig"} displays a summary of altered proteins in each functional category, which emphasizes the unique dysregulation of protein expression in the hippocampal synaptic junctions of susceptible and unsusceptible groups. A larger group of proteins involved in membrane trafficking and mitochondrial functions were markedly upregulated in the unsusceptible group, implying their association with CMS resistance. Similarly, we also found that a larger group of proteins involved in regulatory/chaperone activity were significantly changed in susceptible rats. In view of specific alteration patterns of the presynaptic trafficking proteins in the unsusceptible group, we focused on this protein class in the following analysis ([Table 2](#T2){ref-type="table"}).

Western-Blot Detection of Stress-Related Presynaptic Trafficking and SNARE Proteins {#s15}
-----------------------------------------------------------------------------------

To validate the identification of CMS-responsive proteins detected from the proteomic experiment and to compare the synaptic transmission mechanisms of susceptible and unsusceptible rats, a few membrane proteins of interest (Syn1, Stxbp1 \[also known as Munc18-1\], and Rab3a) were selected for further analysis by immunoblotting based on in-depth network exploitation of the identified trafficking proteins ([Figure 8a](#F8){ref-type="fig"}) and the availability of commercial antibodies. To probe into the possible mechanism(s), an additional set of 5 targeted proteins involved in presynaptic neurotransmission (ie, the core components of soluble N-ethylmaleimide-sensitive factor attachment protein receptor \[SNARE\] complex, including Stx1a, Stx1b, SNAP25, VAMP2, and its key regulator Syt1) were also taken into consideration for immunoblotting analysis, even though they were not differentially expressed in the iTRAQ experiments.

![Analysis of synaptic junction proteins involved in membrane trafficking after CMS. (*a*) STRING interaction network of the focus trafficking proteins. Four additional interplay proteins were added to this network. An interaction map was generated using default settings (ie, a high confidence level of 0.7 and 7 linkage criteria: neighborhood, gene fusion, cooccurrence, coexpression, experimental evidence, existing database(s), and text mining). (*b*) Membrane-associated GTP-bound Rab3a and Munc18-1, through co-regulating syntaxin-1/SNAP25/VAMP2 assembly, appears to facilitate soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-mediated membrane fusion and resulting neurotransmitter release in the hippocampal presynaptic active zones of unsusceptible rats.](ijnppy_pyv100_f0008){#F8}

As shown in the Western blots ([Figure 9a](#F9){ref-type="fig"}), the expression level of Munc18-1 and Syn1 appeared to be upregulated, whereas Rab3a was significantly downregulated, in synaptic junctional extracts from the unsusceptible group compared with the susceptible and control groups. Moreover, 4 proteins (Stx1a, Stx1b, SNAP25, and VAMP2) of the remaining 5 proteins displayed marked dysregulation by immunoblotting, yet these proteins did not show comparable group regulation patterns in our iTRAQ analysis. Similar discrepancies have also been observed in other proteomic studies ([@CIT0001]; [@CIT0003]; [@CIT0049]; [@CIT0014]), probably due to either differences of dynamic range between iTRAQ and immunoblotting ([@CIT0001]) or the intrinsic variability associated with the procedural steps of proteomic and immunoblotting analysis. A few potential changes could be masked and missed, which can be partially attributed to the fact that iTRAQ suffers to some extent from the compression of the quantitation ratios to a ratio of 1.0 when used with complex samples. In most cases, changes in the levels as assessed by immunoblotting were larger than observed by iTRAQ; thus, immunoblotting could indicate some results that were not observed in iTRAQ analysis ([@CIT0017]).

![Immunoblotting of select presynaptic membrane proteins. Immunoblotting of the (*a*) synaptic junction, (*b*) Ves, (*c*) Syn, and (*d*) total Hom preparations from hippocampi of the control, susceptible, and unsusceptible groups. Rab3a, Stxbp1 (also known as Munc18-1), Syn1, Syt1, Stx1a, Stx1b, SNAP25, and VAMP2 were detected with their respective antibodies (left). Each blot is representative of triplicate findings, and the protein load was checked by Coomassie-stained gels. The bands for the same proteins were analyzed by densitometry using Quality One software (right). The *X* axis shows the relative intensity. All data were derived from three independent experiments and are shown as mean±SE. \**P\<.*05, \*\**P\<.*01. C, control; U, unsusceptible; S, susceptible.](ijnppy_pyv100_f0009){#F9}

To gain a more comprehensive view of the data, we examined the different expression patterns of the 8 proteins in the additional subcellular compartmentalization, including the aforementioned Ves, Syn, and Hom preparations ([Figure 9b](#F9){ref-type="fig"}-d). Looking at the whole figure, more alterations of these proteins appeared at synaptic junctions vs the other 3 neuronal fractions. With regard to total Hom extracts ([Figure 9d](#F9){ref-type="fig"}), the decreased expression level of SNAP25 was found in the unsusceptible group when compared with the control and susceptible groups, whereas an opposite trend was shown at the synaptic junctions; this can be partly explained in terms of its known extra-synaptic localization ([@CIT0112]; [@CIT0036]). Besides Stx1b and Syt1, we found no significant changes in the levels of the other 5 proteins examined in total hippocampal Hom. From the Syn fraction ([Figure 9c](#F9){ref-type="fig"}), the levels of both Stx1a and Stx1b were found to be significantly upregulated in the unsusceptible group compared with both the control and susceptible groups; the same expression pattern was detected in the synaptic junctions. In combination with the results from [Figure 9b](#F9){ref-type="fig"}, the specific CMS insusceptibility-related alterations of Stx1a and Stx1b were found to be nonexistent in the soluble extra-junctional Ves fraction but were found in the insoluble junctional lattices that represent different subcellular compartments ([@CIT0112]; [@CIT0088]). Furthermore, the alterations of Rab3a and Munc18-1 expression levels existed only in the synaptic junctions, which may be concealed by the total protein levels ([@CIT0067]; [@CIT0112]; [@CIT0120]). Taken together, the distinct phenotypic states of these proteins in multiple compartments of neurons suggest that they interact with several distinct scaffolding proteins and play diverse roles in synapses. In this respect, the synapse-specific alterations of these proteins may be partially covered due to their extra-synaptic expression characteristics ([@CIT0112]; [@CIT0036]; [@CIT0088]; [@CIT0120]).

Discussion {#s16}
==========

Segregation of CMS Rats into Susceptible and Unsusceptible Rat Subpopulations {#s17}
-----------------------------------------------------------------------------

Upon exposure to psychological stress, some individuals are prone to developing mood disorders, whereas others progress normally ([@CIT0091]; [@CIT0024]). It has become widely accepted that resilience is not merely a lack of stress susceptibility but is an active process that involves physiological as well as psychological adaptations ([@CIT0057]). Recently, a resilience phenotype has been described in studies employing the chronic social defeat model of depression ([@CIT0057]; [@CIT0025]), and stress susceptibility/resilience has also been assessed following exposure to CMS for the importance of this subgroup ([@CIT0038]). Likewise, here we utilized the CMS paradigm to induce diminished responsiveness to a pleasant event, which mimics anhedonia, one of the core symptoms of MDD ([@CIT0073]). This CMS-induced anhedonic-like behavior was measured as a gradual reduction in sucrose preference. Some animals did not reduce their sucrose intake and appeared resilient to developing anhedonic-like behavior in response to stress. A unique feature of this model was that rats exposed to CMS could be segregated into susceptible and unsusceptible populations based on hedonic readouts from sucrose measurements. This segregation was further confirmed by other behavioral findings; anhedonia in susceptible rats was accompanied by increased FST immobility. However, decreased exploratory behavior was found in both susceptible and unsusceptible rats, indicating that these behavioral features were the consequences of CMS independent of anhedonia. In accordance with previous findings ([@CIT0065]; [@CIT0030]), the locomotor activity measured here was not affected by CMS exposure.

In general, CMS simulates realistic conditions for human depression ([@CIT0077]) and generates multiple behavioral changes similar to those observed clinically, thus supporting the hypothesis that molecular alterations found using this model also occur in human patients with stress-induced depression ([@CIT0039]). In this study, a separation into susceptible and unsusceptible rats provided a useful approach to identifying molecular factors underlying the mechanisms of stress vulnerability as well as molecular adaptations that promote resistance to stress and adversity. As stress resiliency is a common clinical phenomenon, inclusion of the unsusceptible group raises this model's value and provides valuable information for resilience-related translational research ([@CIT0101]).

The Hippocampal Synaptic Junction as a Key Substrate for CMS Resistance {#s18}
-----------------------------------------------------------------------

Our behavioral findings indicate that, compared with the control and unsusceptible groups, the susceptible group exhibited a markedly reduced sucrose preference and time spent in the central sector of the OFT, and increased immobility time during the FST. However, the unsusceptible group displayed a prominent lack of behavioral phenotypic changes, showing only a decrease of rearing number as compared with controls. In the absence of candidate "resistance-associated proteins," we designed a quantitative proteomic experiment to explore the effects of CMS on the hippocampal synaptic proteome and to examine the functional consequences of these alterations with particular emphasis on their relevance to stress sensitivity.

Dysregulated synaptic activity is evident in a host of neurological and psychiatric diseases ([@CIT0046]) such as depression ([@CIT0021]) and schizophrenia ([@CIT0118]). By conducting synapto-proteomic analysis of CMS depressive rats, we previously revealed some hippocampal synaptic exo-/endocytosis-associated proteins that play various roles in synaptic transmission and plasticity that may underlie the pathoetiology of MDD ([@CIT0043]). However, it still remains unclear which (if any) distinct events directed by synaptic proteins occurring in the important subregions, particularly at the active zone, correlate with an animal's response to CMS.

It has been reported that there are synaptic active zones in the synaptic plasma membrane that have critical roles in the release of the neurotransmitter from nerve terminals ([@CIT0072]; [@CIT0103]). The active zone-associated, electron-dense structures (which correspond to synaptic junctions contained in the pre- to postsynaptic scaffold and presynaptic web) were biochemically characterized by the insolubility in TX-100 ([@CIT0081]; [@CIT0060]). For this study, a pH 6 solution containing 1% TX-100 was used to dissolve some molecules that were primarily associated with synaptic vesicles as well as molecules loosely connected to the synaptic junctional scaffold. As expected, the molecules involved in synaptic vesicle dynamics at the presynaptic membrane would be retained in the detergent-insoluble pH 6 synaptic junctional pellet if they were connected to the synaptic scaffold. Thus, in agreement with previously published studies, the synaptosomal- and synaptic junction-enriched fractionation protocol described herein yielded an enrichment of proteins known to be localized to the synaptic active zone with a reduction of cytomatrix proteins. Some presynaptic active zone proteins (such as syntaxin-1, SNAP25, and Munc18-1) were present in the insoluble junctional fraction, which is consistent with the localization of these proteins within the presynaptic membrane specialization and possibly within the 50-nm presynaptic particles themselves ([@CIT0103]). A significant proportion of the proteins was solubilized; however, [Figure 9](#F9){ref-type="fig"} revealed synaptic and nonsynaptic pools of these molecules ([@CIT0112]; [@CIT0036]; [@CIT0088]; [@CIT0120]), and the TX-100 (pH 6) did not solubilize the junction-associated pools of these presynaptic proteins. In fact, many studies clearly showed that the presynaptic web forms a subset of interrelated proteins embedded in the presynaptic membrane specialization, which is composed of synaptic vesicle exocytosis and recycled proteins.

In our study, by means of the biochemical fractionation approach, the enriched synaptic junctions as a molecular vessel served to intensively investigate the complexity of molecular changes hidden at the synaptic active zone through the following iTRAQ-based proteomic analysis. Neurotransmission, synaptic contact, and the short- and long-term structural and functional dynamics are governed by a unique set of proteins at the active zone. The identification of the protein inventory in the synaptic active zone is of utmost importance in understanding the regulation and modulation of chemical signaling along with its pathologies.

To obtain information about the 2 stress-sensitivity phenotypes, the hippocampal synaptic protein profiles from the 3 experimental groups (control, susceptible, and unsusceptible) were established and compared. iTRAQ-labeled peptides were separated and identified by LC-MS/MS, which provided a sensitive and robust quantitative proteomic platform for identifying synaptic molecules of stress reactivity. Functional cluster analysis on all synaptic membrane proteins indicated that, in terms of protein expression levels in the hippocampal synaptic active zone, the unsusceptible phenotype had a distinctly different proteomic profile with respect to protein systems involved in membrane trafficking, transporter, regulatory/chaperone, and mitochondrial functions ([Figure 7c](#F7){ref-type="fig"}). These differential expressions of various proteins indicate that the hippocampal synaptic active zone might be the vital substrate involved with resistance to CMS. Importantly, the unbiased profiling results from this study revealed a series of candidate synaptic proteins whose alterations occurred in the nerve terminal active zone of the unsusceptible group, suggesting that the expression of this phenotype is an active neurobiological process that is not simply the absence of vulnerability ([@CIT0057]).

Rab3a and Munc18-1 Coregulation as a Potential Molecular Adaptation Facilitating SNARE-Mediated Membrane Fusion {#s19}
---------------------------------------------------------------------------------------------------------------

An interesting finding was that the more significantly upregulated proteins in a specific profile for unsusceptible rats, as compared with both the control and susceptible rats, were found to be closely associated with membrane trafficking in synaptic transmission. It can be surmised that expressional changes in these proteins may be involved in the molecular adaptation and stress-coping mechanism in unsusceptible rats. To our knowledge, the presynaptic active zone, characterized by numerous synaptic vesicles docked to the presynaptic plasma membrane ([@CIT0062]; [@CIT0079]), is the key site of synaptic vesicle fusion and is thus of central importance for the chemical communication between neurons and neighboring cells ([@CIT0079]; [@CIT0103]). The docking process of synaptic vesicles is mediated by the concerted action of 3 proteins (syntaxin-1, SNAP25, and VAMP2) that form a highly stable bundle of 4 parallel α-helices (the core SNARE complex) that drives vesicle fusion ([@CIT0090]; [@CIT0045]; [@CIT0098]). Previous studies have indicated that SNARE protein expression levels affect docking, priming, and release probabilities ([@CIT0086]), and the assembly process of syntaxin-1/SNAP25/VAMP2 in the presynaptic active zone controls presynaptic neurotransmitter release ([@CIT0009]; [@CIT0079]).

Centered around this core machinery for membrane fusion, we combined all the identified differential trafficking proteins with the core SNARE components to create a network map through STRING analysis in an attempt to find possible internal linkages and associated partners. As shown in [Figure 8a](#F8){ref-type="fig"}, [4](#F8){ref-type="fig"} proteins from the aforementioned proteomic analysis, namely Rab3a, Munc18-1, Syn1, and Napa, were highly correlated with SNARE-mediated membrane fusion.

Through further selective immunoblotting of the 4 different fractions, we found an accumulation of membrane-associated Rab3a form in the unsusceptible group as compared with the control and susceptible groups; this protein is GTP-bound (not cytosolic GDP-bound) and is therefore the active form ([@CIT0027]; [@CIT0012]). Rab3a is a small neuronal GTP-binding protein that localizes to synaptic vesicles and plays a key regulatory role in Ca^2+^-dependent exocytosis, particularly in neurotransmitter release from nerve terminals ([@CIT0102]; [@CIT0093]). Rab3a has a function upstream of vesicle fusion in the activity-dependent transport of synaptic vesicles to and from their docking in the active zone ([@CIT0058]). As a GTP-dependent molecular switch, Rab3a is able to improve the fidelity of protein-protein interactions at the targets of a transport step, such as the pairing of SNARE proteins ([@CIT0099]; [@CIT0076]; [@CIT0095]; [@CIT0031]) and acting upstream of SNARE complex formation between the vesicle and target membrane ([@CIT0028]; [@CIT0047]; [@CIT0029]; [@CIT0097]; [@CIT0018]). Some previous studies have found that Rab3a is an interacting partner of Syt1 and may participate in the regulation of synaptic membrane fusion by competitively modulating the interaction of synaptotagmin with syntaxin-1 of the SNARE complex in presynaptic membranes ([@CIT0041]; [@CIT0117]). Intriguingly, in the presynaptic active zone, we found elevated levels of syntaxin-1A/1B in the unsusceptible phenotype relative to the control and susceptible groups, possibly due to direct competition between the membrane-associated GTP-bound Rab3a and syntaxin-1 for the same binding site within the C2B domain of Syt1 ([@CIT0117]). Moreover, the expression of Syt1 (as an exocytic Ca^2+^ sensor) showed no significant change in the active zone of the synapse ([@CIT0052]). Therefore, we speculate that the large reduction of GTP-bound Rab3a at the synaptic active zone of unsusceptible rats may lead to its reduced interaction with Syt1, which in turn leads to an increased interaction of Syt1 with syntaxin-1, thereby promoting SNARE complex formation and facilitating membrane fusion during exocytosis ([@CIT0105]; [@CIT0117]).

Syntaxin-1 and Munc18-1 have been postulated to function as docking and fusion platforms for synaptic vesicles ([@CIT0111]; [@CIT0035]; [@CIT0010]). Munc18-1 is a molecular chaperone of syntaxin-1 by virtue of its tight binding ([@CIT0033]; [@CIT0042]), which is involved in SNARE-mediated membrane fusion and the docking of large dense-core vesicles to the plasma membrane ([@CIT0108]; [@CIT0037]). In this study, Munc18-1 expression was found to be upregulated in the active zone of unsusceptible rats, thereby directly promoting syntaxin-1 stability and regulating the formation of vesicle priming. Thus, elevated Munc18-1 may act as a compensatory regulator of accelerated syntaxin-1 ([@CIT0126]), binding simultaneously to the SNARE complex to control the assembly of the Munc18-1/SNARE membrane fusion complex ([@CIT0107]; [@CIT0126]; [@CIT0054]; [@CIT0087]; [@CIT0061]).

Finally, to address whether additional core components of the SNARE complex were affected, SNAP25 and VAMP2 expression in the synaptic junction was analyzed. SNAP-25 is a membrane-bound protein anchored via the palmitoylation of cysteines in the linker region that connects the 2 SNARE motifs ([@CIT0026]). Syntaxin-1 and VAMP2 are anchored via transmembrane domains ([@CIT0018]). After the docking and priming of synaptic vesicles, VAMP2 interacts with SNAP-25 and syntaxin-1 to form a transient SNARE complex that mediates membrane fusion by bringing the vesicle and the presynaptic plasma membrane at the active zone to release the neurotransmitter ([@CIT0104]). In unsusceptible rats, significant SNAP25 upregulation was observed compared with controls, and VAMP2 also showed a similar upregulation when compared with susceptible rats. These findings reveal that the syntaxin-1/SNAP25/VAMP2 assembly ([@CIT0078]) for the fusion event was affected in the unsusceptible rats. This effect shows a high level of specificity for stress insusceptibility that can be demonstrated by particular changes in the relative amounts of SNARE proteins.

In sum, our findings support a molecular adaptation on synaptic transmission in unsusceptible rats and especially on SNARE-related components. The accessory proteins (membrane-associated GTP-bound Rab3a and Munc18-1) may facilitate SNARE-mediated membrane fusion and the subsequent release and recycling of neurotransmitters by coregulating syntaxin-1/SNAP25/VAMP2 assembly at the presynaptic active zone of unsusceptible rats ([Figure 8b](#F8){ref-type="fig"}) ([@CIT0008]; [@CIT0013]). However, the precise mechanism(s) that orchestrate the differential behavioral responses to stress, with particular respect to stress resilience, still require further investigation.

Conclusions {#s20}
===========

In this study, we used a quantitative proteomic approach to investigate the alterations of synaptic junctional protein expression in the hippocampus of rats subjected to CMS. The unbiased profiles identified several candidate proteins in the synaptic active zone that may be related to stress vulnerability or insusceptibility and provide insight into the pathogenesis of stress-related disorders. On the subcellular proteome level, this study provides preliminary evidence that protein modulations in the synaptic active zone are causally linked to behavioral adaptations to stress. Moreover, our data support the concept that there is dysregulation of synaptic transmission and protein systems particularly involved in membrane trafficking in the active zone of unsusceptible rats, revealing new investigative protein targets that may contribute to a better understanding of stress resilience. Through STRING and immunoblotting analysis, membrane-associated GTP-bound Rab3a and Munc18-1 appear to coregulate syntaxin-1/SNAP25/VAMP2 assembly at the hippocampal presynaptic active zone of unsusceptible rats, thereby facilitating SNARE-mediated membrane fusion and neurotransmitter release. The activity of these 2 proteins may be a part of a stress-protection mechanism that actively maintains emotional homeostasis under stressful conditions.
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